Home › Funds › BARROW HANLEY MEWHINNEY & STRAUSS LLC › MDT
BARROW HANLEY MEWHINNEY & STRAUSS LLC position in MDT
MEDTRONIC PLC · Health Care
BARROW HANLEY MEWHINNEY & STRAUSS LLC reported holding 3,687,628 shares of MDT (MEDTRONIC PLC) in its Q3 2026 13F filing — a position valued at US$318.2M, representing 1.01% of its reported portfolio and ranking #36 among its reported holdings. BARROW HANLEY MEWHINNEY & STRAUSS LLC has disclosed MDT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BARROW HANLEY MEWHINNEY & STRAUSS LLC's MDT position evolved
BARROW HANLEY MEWHINNEY & STRAUSS LLC first disclosed a stake in MDT in Q3 2023 at 6,213,260 shares (US$486.9M). The position peaked in Q1 2024 at 6,227,544 shares, worth US$542.7M. Across 13 filings, BARROW HANLEY MEWHINNEY & STRAUSS LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 3,687,628 shares valued at US$318.2M — a reduction of -62,891 shares quarter over quarter.. Notable position changes include a 40% trim in Q3 2024 (shares fell 11% over the following quarter), a 25% increase in Q1 2025 (shares fell 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.21M | $486.87M | New |
| Q4 2023 | 6.43M | $530.01M | Add |
| Q1 2024 | 6.23M | $542.73M | Reduce |
| Q2 2024 | 5.99M | $471.52M | Reduce |
| Q3 2024 | 3.60M | $324.12M | Reduce |
| Q4 2024 | 3.53M | $282.02M | Reduce |
| Q1 2025 | 4.42M | $396.77M | Add |
| Q2 2025 | 4.40M | $383.43M | Hold |
| Q3 2025 | 4.40M | $418.99M | Hold |
| Q4 2025 | 4.18M | $401.13M | Reduce |
| Q1 2026 | 4.07M | $352.77M | Reduce |
| Q2 2026 | 3.75M | $293.40M | Reduce |
| Q3 2026 | 3.69M | $318.21M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDT and 13F data
MDT (MEDTRONIC PLC) is a Health Care company. 20 other funds we track also report a position in MDT — the largest reported positions include MFS Investment Management (US$2.56B), Deutsche Bank AG (US$1.55B), First Eagle Investment Management (US$1.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDT
- MFS Investment Management 18.09M sh · $2.56B · Q3 2026
- Deutsche Bank AG 18.00M sh · $1.55B · Q3 2026
- First Eagle Investment Management 13.95M sh · $1.20B · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 12.23M sh · $1.06B · Q3 2026
- Arrowstreet Capital 12.89M sh · $1.01B · Q2 2026
More on BARROW HANLEY MEWHINNEY & STRAUSS LLC
FAQ
How long has BARROW HANLEY MEWHINNEY & STRAUSS LLC held MDT?
BARROW HANLEY MEWHINNEY & STRAUSS LLC has disclosed MDT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is BARROW HANLEY MEWHINNEY & STRAUSS LLC's current position in MDT?
As of Q3 2026, BARROW HANLEY MEWHINNEY & STRAUSS LLC holds 3.69M shares of MDT (MEDTRONIC PLC), valued at $318.21M, representing 1.01% of its reported portfolio and ranking #36.
Has BARROW HANLEY MEWHINNEY & STRAUSS LLC been buying or selling MDT?
In the latest 13F filing (Q3 2026), BARROW HANLEY MEWHINNEY & STRAUSS LLC reduced its position in MDT. The position peaked in Q1 2024 at 6.23M shares.
Which other funds hold MDT?
Other major institutional holders of MDT include MFS Investment Management, Deutsche Bank AG, First Eagle Investment Management, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.